| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.26 | 0.004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.03 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |